![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 471/14 | (2006.01) | ||
C07D 498/14 | (2006.01) | ||
A61K 31/4439 | (2006.01) | ||
A61P 11/12 | (2006.01) |
(11) | Patento numeris | 3519401 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17792230.9 |
Europos patento paraiškos padavimo data | 2017-09-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
(46) | Apibrėžties vertimo paskelbimo data | 2021-11-25 |
(86) | Numeris | PCT/US2017/054611 |
Data | 2017-09-29 |
(87) | Numeris | WO 2018/064632 |
Data | 2018-04-05 |
(30) | Numeris | Data | Šalis |
201662402838 P | 2016-09-30 | US | |
201662410353 P | 2016-10-19 | US | |
201662415409 P | 2016-10-31 | US | |
201662419935 P | 2016-11-09 | US |
(72) |
ALCACIO, Timothy , US
BAEK, Minson , US
GROOTENHUIS, Peter , US
HADIDA RUAH, Sara, Sabina , US
HUGHES, Robert, M. , US
KESHAVARZ-SHOKRI, Ali , US
MCAULEY-AOKI, Rachel , US
MCCARTNEY, Jason , US
MILLER, Mark, Thomas , US
VAN GOOR, Fredrick , US
ZHANG, Beili , US
ANDERSON, Corey , US
CLEVELAND, Thomas , US
FRIEMAN, Bryan, A. , US
KHATUYA, Haripada , US
JOSHI, Pramod, Virupax , US
KRENITSKY, Paul, John , US
MELILLO, Vito , US
PIERRE, Fabrice, Jean Denis , US
TERMIN, Andreas, P. , US
UY, Johnny , US
ZHOU, Jinglan , US
ABELA, Alexander, Russell , US
BUSCH, Brett, Bradley , US
PARASELLI, Prasuna , US
SIESEL, David, Andrew , US
|
(73) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Cistinės fibrozės transmembraninio laidumo reguliavimo moduliatorius, farmacinės kompozicijos, gydymo būdai ir moduliatoriaus gamybos būdas |
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR |
Mokėjimo data | Galiojimo metai | Suma | |
2024-09-02 | 8 | 185.00 EUR |
2025-09-29 |